Predictors of Hypertension Awareness, Treatment, and Control Among Mexican American Women and Men
- 210 Downloads
The burden of hypertension and related health care needs among Mexican Americans will likely increase substantially in the near future.
In a nationally representative sample of U.S. Mexican American adults we examined: 1) the full range of blood pressure categories, from normal to severe; 2) predictors of hypertension awareness, treatment and control and; 3) prevalence of comorbidities among those with hypertension.
Cross-sectional analysis of pooled data from the National Health and Nutrition Examination Surveys (NHANES), 1999–2004.
The group of participants encompassed 1,359 Mexican American women and 1,421 Mexican American men, aged 25–84 years, who underwent a standardized physical examination.
Physiologic measures of blood pressure, body mass index, and diabetes. Questionnaire assessment of blood pressure awareness and treatment.
Prevalence of Stage 1 hypertension was low and similar between women and men (∼10%). Among hypertensives, awareness and treatment were suboptimal, particularly among younger adults (65% unaware, 71% untreated) and those without health insurance (51% unaware, 62% untreated). Among treated hypertensives, control was suboptimal for 56%; of these, 23% had stage ≥2 hypertension. Clustering of CVD risk factors was common; among hypertensive adults, 51% of women and 55% of men were also overweight or obese; 24% of women and 23% of men had all three chronic conditions-hypertension, overweight/obesity and diabetes.
Management of hypertension in Mexican American adults fails at multiple critical points along an optimal treatment pathway. Tailored strategies to improve hypertension awareness, treatment and control rates must be a public health priority.
KEY WORDSMexican American hypertension health care practice patterns secondary prevention
The authors thank Dr. David Ahn for his statistical and analytical expertise and Alana Koehler for her technical assistance in preparing the tables and figures. This research was supported by Public Health Service Training Grants T32 HL 07034 (AB) and K24 HL 086703 (RSS), both from the National Heart, Lung, and Blood Institute. This project was also supported by the Network for Multicultural Research on Health and Healthcare, Dept. of Family Medicine - UCLA David Geffen School of Medicine, funded by the Robert Wood Johnson Foundation.
- 3.Neal B, MacMahon S, Chapman N; Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. The Lancet 2000;356(9246):1955–64.CrossRefGoogle Scholar
- 8.US Census Bureau. 2008 National Population Projections. 2008 [cited 2008 November 18]; Available from: http://www.census.gov/population/www/projections/tablesandcharts.html
- 11.DeNavas-Walt C, Proctor B, Smith J. Income, poverty, and health insurance coverage in the United States: 2007. Washington DC: US Government Printing Office; 2008.Google Scholar
- 16.Farquhar I JJ, Weir E. Costs of concomitant illnesses among patients with hypertension and diabetes. Abstr Acad Health Serv Res Health Policy Meet 2000.Google Scholar
- 19.National Center for Health Statstics. Response Rates & CPS Population Totals. 2009 [cited 2009 July 23]; Available from: http://www.cdc.gov/nchs/nhanes/nhanes_cps_totals.htm
- 21.Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26 Suppl 1:S5–20.Google Scholar
- 22.Neese JW, Duncan P, Bayse DD, et al. Development and evaluation of a hexokinase/glucose-6-phosphate dehydrogenase procedure for use as a national glucose reference method. HEW Publication No. (CDC) 77–8330. HEW. USPHS, Centers for Disease Control and Prevention, 1976.Google Scholar
- 34.Bersamin A, Hanni KD, Winkleby MA. Predictors of trying to lose weight among overweight and obese Mexican-Americans: a signal detection analysis. Public Health Nutr. 2008:1–10.Google Scholar
- 35.Prognosis in hypertension. Br Med J. 1970;4(5737):697–8.Google Scholar
- 41.Leitschuh M, Cupples LA, Kannel W, Gagnon D, Chobanian A. High-normal blood pressure progression to hypertension in the Framingham Heart Study. Hypertension 1991;12(1):22–27.Google Scholar
- 42.Huttin C, Moeller J, Stafford R. Patterns and costs for hypertension treatment in the United States: clinical, lifestyle and socioeconomic predictors from the 1987 national medical expenditures survey clinical drug investigation 2000;20(3):181–95.Google Scholar
- 45.National Center for Chronic Disease Prevetion and Health Promotion. Behavioral Risk Factor Surveillance System. 2008; Available from: http://www.cdc.gov/brfss//
- 46.Chong Y, Carroll M, Burt V, Montalvan P. NHANES converted refusals: are they different from willing respondents in cardiovascular risk factors? In: American Association For Public Opinion Association; 2009; Miami Beach, FL; 2009.Google Scholar